KUALA LUMPUR (Nov 13): Co’s plans to introduce world’s first non-bleaching antimicrobial nitrile examination glove by 1H 2018 would allow the group to benefit from a pricing premium of 10% to 15%, writes Walter Aw, analyst at CIMB Investment Bank, in a report.
* Product should be popular with the healthcare industry
** Active protective layer inside glove to prevent cross contamination in healthcare facilities; 99.9% of germs and bacteria on the user’s hands are able to be eliminated within 5 minutes of contact
* Other glove producers may play catch-up in the next 2-3 years by developing similar products
* Stock maintained at add; PT unchanged at 9 ringgit
* Stock gains as much as 6.7%, set for highest close on record
http://www.theedgemarkets.com/article/hartalega-rises-record-cimb-sees-new-product-catalyst
